New hope for stomach cancer patients: drug combo shows promise
NCT ID NCT06680622
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times
Summary
This study tests a drug called bemarituzumab combined with different chemotherapies for people with advanced stomach or gastroesophageal junction cancer that has a specific marker (FGFR2b). Participants have already tried at least one chemotherapy that didn't work. The goal is to see if the new combination can shrink tumors or slow cancer growth. About 126 adults are taking part, and they receive one of three chemo combos chosen by their doctor.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC GASTRO-ESOPHAGEAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité - Universitätsmedizin Berlin Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie (CVK)
Berlin, 13353, Germany
-
Gemeinschaftspraxis Hämatologie-Onkologie
Dresden, 01307, Germany
-
HELIOS Kliniken Schwerin
Schwerin, Germany
-
Helios Klinikum Bad Saarow
Bad Saarow, Germany
-
Hämatologisch-Onkologische Praxis Eppendorf (hope) Norddeutsches Studienzentrum für Innovative Onkologie
Hamburg, 20249, Germany
-
Kliniken Essen-Mitte
Essen, Germany
-
Klinikum Bielefeld gem. GmbH Klinik für Hämatologie, Onkologie und Palliativmedizin
Bielefeld, Germany
-
Klinikum Chemnitz
Chemnitz, Germany
-
Klinikum Magdeburg
Magdeburg, Germany
-
Klinikum München-Bogenhausen
München, Germany
-
Klinikum Neukölln Vivantes Netzwerk für Gesundheit GmbH Klinlinik für Innere Medizin - Hämatologie und Onkologie
Berlin, 12351, Germany
-
Klinikum St. Marien
Amberg, Germany
-
Klinikum Wolfsburg Medizinische Klinik II
Wolfsburg, 38440, Germany
-
Klinikum der Universität München Med. Klinik und Poliklinik III AG Onkologie
München, Germany
-
Klinikum rechts der Isar der technischen Univeristät München Medizinische Klinik und Poliklinik III Hämatologie und Onkologie
München, 81675, Germany
-
Krankenhaus Barmherzige Brüder Regensburg Klinik für Onkologie und Hämatologie
Regensburg, 93049, Germany
-
Krankenhaus Nordwest GmbH Institut für Klinisch-Onkologische Forschung (IKF)
Frankfurt, Germany
-
Kreiskliniken Reutlingen gGmbH Klinikum am Steinenberg Reutlingen/Medizinische Klinik I
Reutlingen, 72746, Germany
-
MH Hannover
Hanover, Germany
-
Medizinisches Versorgungszentrum Landshut
Landshut, Germany
-
Onkodoc Gütersloh
Gütersloh, 33332, Germany
-
St. Anna Hospital Herne
Herne, 44649, Germany
-
St.-Johannes-Hospital
Dortmund, 44137, Germany
-
Uniklinik RWTH Aachen
Aachen, 52074, Germany
-
Universitäres Krebszentrum Leipzig (UCCL)
Leipzig, 04103, Germany
-
Universität Göttingen
Göttingen, Germany
-
Universitätsklinikum Augsburg
Augsburg, Germany
-
Universitätsklinikum Düsseldorf Klinik für Gastroenterologie, Hepatologie und Infektiologie Gastroonkologische Studienzentrale
Düsseldorf, 40225, Germany
-
Universitätsklinikum Gießen und Marburg GmbH Standort Gießen Medizinische Klinik IV; Organonkologie Studienzentrale
Giessen, 35392, Germany
-
Universitätsklinikum Heidelberg Nationales Centrum für Tumorerkrankungen (NCT Heidelberg)
Heidelberg, 69120, Germany
-
Universitätsklinikum Jena
Jena, Germany
-
Universitätsklinikum Regensburg
Regensburg, 93042, Germany
-
Universitätsklinikum Schleswig-Holstein
Kiel, Germany
-
Universitätsmedizin Mainz I. Medizinische Klinik und Poliklinik
Mainz, 55131, Germany
-
VIVANTES Berlin Friedrichshain
Berlin, Germany
Conditions
Explore the condition pages connected to this study.